KalVista Pharmaceuticals
KALV
KALV
76 hedge funds and large institutions have $153M invested in KalVista Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
53% less capital invested
Capital invested by funds: $328M → $153M (-$175M)
Holders
76
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.22M | |
| 3 | +$1.06M | |
| 4 |
Squarepoint
New York
|
+$611K |
| 5 |
O
OrbiMed
New York
|
+$449K |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$3.79M | |
| 3 | -$2.86M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.18M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$880K |